Semaphorin 3A 通过调节免疫反应抑制变应性鼻炎小鼠模型的变应性炎症
该研究检测了变应性鼻炎患者和小鼠模型的血清 sema3A 表达,并在卵清蛋白致敏小鼠中经鼻给予 sema3A,分析症状、IgE、细胞因子、组织学及脾脏 T 细胞亚群。结果显示 sema3A 降低变应性症状评分、嗜酸性粒细胞浸润和 OVA 特异性 IgE,抑制 Th2/Th17 反应并增强 Th1/Treg 反应。
要点
- 变应性鼻炎患者和 OVA 致敏小鼠血清 sema3A 水平较对照显著降低。
- 经鼻给予 sema3A 可减轻 OVA 致敏小鼠变应性症状评分、嗜酸性粒细胞浸润和 OVA 特异性 IgE 产生。
- sema3A 抑制 Th2/Th17 反应并增强 Th1/Treg 反应。
核心结论
- sema3A 通过抑制 Th2/Th17 反应和增强 Th1/Treg 反应,抑制变应性鼻炎中的变应性炎症。
研究设计与样本
- 研究检测了变应性鼻炎患者血清和 OVA 致敏小鼠模型中的 sema3A 表达。
- 在 OVA 致敏小鼠、sema3A 小鼠、给予生理盐水的小鼠和对照中,分析鼻部症状、OVA 特异性 IgE 产生、细胞因子水平和组织学结构。
- 还分析了脾脏中 CD4+ IL-4+ IFN-γ- Th2 细胞、CD4+ IFN-γ+ IL-4- Th1 细胞、CD4+ IL-17+ Th17 细胞和 CD4+ CD25+ Foxp3+ Treg 细胞的百分比。
主要发现
- 变应性鼻炎患者和 OVA 致敏小鼠的血清 sema3A 水平均较对照显著降低。
- 经鼻给予 sema3A 降低了 OVA 致敏小鼠的变应性症状评分、嗜酸性粒细胞浸润和 OVA 特异性 IgE 产生。
- 给予 sema3A 后,IL-4 和 IL-17 水平以及 CD4+ IL-17+ Th17 细胞百分比受到抑制。
- 给予 sema3A 后,IFN-γ 和 IL-10 水平、CD4+ IFN-γ+ IL-4- Th1/CD4+ IL-4+ IFN-γ- Th2 细胞比值以及 CD4+ CD25+ Foxp3+ Treg 细胞百分比升高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: It has been reported that semaphorin 3A (sema3A) could improve allergic symptoms in allergic rhinitis (AR) mice. However, the immunomodulatory roles of sema3A in AR remain unclear. This study was performed to determine the immunoregulatory effects of sema3A on airway inflammation in an AR mice model. METHODS: First, sema3A expression was measured in the serum of AR patients and also in a mice model. Then, nasal symptoms, ovalbumin (OVA)-specific immunoglobulin E (IgE) production, cytokine levels, and histologic structure were analyzed in OVA-sensitized mice, sema3A mice, mice given saline, and controls. The percentages of CD4+ IL-4+ IFN-γ- Th2 cells, CD4+ IFN-γ+ IL-4- Th1 cells, CD4+ IL-17+ Th17 cells, and CD4+ CD25+ Foxp3+ Treg cells in the spleen were also analyzed. RESULTS: Serum sema3A levels in both AR patients and OVA-sensitized mice decreased significantly compared with controls. The intranasal administration of sema3A reduced allergic symptom scores, eosinophil infiltration, and OVA-specific IgE production in OVA-sensitized mice. In addition, levels of IL-4 and IL-17 as well as percentages of CD4+ IL-17+ Th17 cells were suppressed by sema3A administration. Levels of IFN-γ and IL-10 and ratios of CD4+ IFN-γ+ IL-4- Th1/CD4+ IL-4+ IFN-γ- Th2 cells, as well as percentages of CD4+ CD25+ Foxp3+ Treg cells, were increased by administration of sema3A. CONCLUSION: Our results demonstrate that sema3A suppressed allergic inflammation in AR via inhibition of Th2/Th17 responses and enhancement of Th1/Treg responses.
引用
- Xiang R, Xu Y, Zhang W, et al. Semaphorin 3A inhibits allergic inflammation by regulating immune responses in a mouse model of allergic rhinitis. Int Forum Allergy Rhinol. 2018. PMID: 30597767. doi:10.1002/alr.22274
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。